[Fear of the injection must not be an argument. Every second type 2 diabetic patient needs insulin].
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005239:Fear; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007279:Injections, Subcutaneous / Q000523:psychology*; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D012803:Sick Role; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D013453:Sulfonylurea Compounds; D000069036:Insulin Glargine; C057619:glimepiride